S G Arbuck

Cyclin-dependent kinases: initial approaches to exploit a novel therapeutic target.

L Meijer, L. Meijer, E. Sausville, 1999, Pharmacology & therapeutics.

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada.

M Van Glabbeke, J Verweij, M. van Glabbeke, 2000, Journal of the National Cancer Institute.

Accelerated titration designs for phase I clinical trials in oncology.

R Simon, R. Simon, M. Christian, 1997, Journal of the National Cancer Institute.

Prospective evaluation of a model for predicting etoposide plasma protein binding in cancer patients.

W. Evans, S. Arbuck, C. Stewart, 1990, Cancer research.

Clinical trial designs for cytostatic agents: are new approaches needed?

R Simon, E L Korn, R. Simon, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Workshop on phase I study design. Ninth NCI/EORTC New Drug Development Symposium, Amsterdam, March 12, 1996.

S. Arbuck, S G Arbuck, 1996, Annals of oncology : official journal of the European Society for Medical Oncology.